Jonathan M Spergel

). Read article or submit your manuscript for publishing."/>
skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8129

Pimecrolimus cream in the management of patients with atopic eczema

Review

(3956) Views  (861) Full article downloads

Author:

Jonathan M Spergel

Published Date May 2009 Volume 2009:2 Pages 85 - 93
DOI: http://dx.doi.org/10.2147/CCID.S3377

Jonathan M Spergel

Division of Allergy and Immunology, The Children’s Hospital of Philadelphia Department of Pediatrics, University of Pennsylvania School of Medicine

Abstract: Atopic eczema is a common pediatric skin disorder. This review examines the use of pimecrolimus cream in the treatment of acute and chronic stages of the disease. The standard therapy is the treatment of acute flares with topical medications including pimecrolimus. The use of pimecrolimus cream for the first sign and symptoms of atopic eczema reduces the occurrence of flares as defined by the need for topical corticosteroids. The side effects of pimecrolimus cream are mild without any increase of infections or systemic immune suppression.

Keywords: pimecrolimus, atopic eczema, long-term management
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University

  • American Acne and Rosacea Society

    The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.